Financial Securities Claims
If fraudulent activities have caused you or your clients damages, we can help you discover if your claim is common among other parties invested in or affected by the performance of the security.
We collaborate with economists to estimate exposure and liabilities for defendants, and assess damages for plaintiffs based on prior shareholder class actions to maximize recovery.
Our Approach to Financial Securities Claims
Our attorneys represent shareholders and fund managers in securities class and derivative litigation, providing staunch representation and access to our vast knowledge and experience. We analyze the magnitude of our clients’ cases and counsel them regarding the Securities Exchange Act of 1934 and other laws governing the exchange of securities.
We collaborate with economists and utilize our knowledge of prior shareholder class actions to maximize recovery for plaintiffs and estimate exposure and liabilities for defendants in claims involving:
- Dissemination of false and misleading financial information
- Approval of corporate mergers and acquisitions not in the best interests of shareholders
- Fraudulent sales of securities or investment products
- Violations of the Securities Exchange Act of 1934 and other federal and state securities laws
Free Financial Securities Claims Consultation
We assist clients with securities claims in state and federal court in Illinois, Missouri and across the country. We are ready to discuss your specific legal needs and aggressively pursue the compensation you deserve.
“Your knowledge, patience, and comfortable approach made this experience much easier for me.”
“Your firm is so professional. They make me feel like family more than anything else. Everyone is very kind and courteous. They go to no limits to get the job done.”
“I get answers to all my questions the day I call, that alone is wonderful. I am very happy to have Goldenberg Heller & Antognoli representing me.”
Notable Settlements & Verdicts
Obtained over $1 million in settlements for individuals injured by a pharmaceutical drug that increased the risk of cancer.